P1‐065: LATE STAGE ALZHEIMER'S DRUGS HIGHLIGHT INNOVATIONS IN TREATMENT: AN ANALYSIS OF THE PHASE 2 AND 3 ALZHEIMER'S DRUG PIPELINE. (1st July 2006) - Morgan, Dave